147 related articles for article (PubMed ID: 37082061)
61. Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation.
Karnam S; Girish HC; Nayak VN
J Oral Maxillofac Pathol; 2022; 26(2):199-207. PubMed ID: 35968184
[TBL] [Abstract][Full Text] [Related]
62. Status of Serum and Salivary Ascorbic Acid in Oral Potentially Malignant Disorders and Oral Cancer.
Bhat S; Babu SG; Bhat SK; Castelino RL; Rao K; Madi M
Indian J Med Paediatr Oncol; 2017; 38(3):306-310. PubMed ID: 29200679
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
64. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma.
Punyani SR; Sathawane RS
Clin Oral Investig; 2013 Mar; 17(2):517-24. PubMed ID: 22526890
[TBL] [Abstract][Full Text] [Related]
65. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
66. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
Shraddha KS; Niranjan KC; Hallikeri K
J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
[TBL] [Abstract][Full Text] [Related]
67. Estimation of serum copper and zinc levels in oral submucous fibrosis: an atomic absorption spectroscopic study.
Neethi H; Patil S; Rao RS
J Contemp Dent Pract; 2013 Sep; 14(5):801-5. PubMed ID: 24685778
[TBL] [Abstract][Full Text] [Related]
68. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
[TBL] [Abstract][Full Text] [Related]
69. Myofibroblasts could be recruited in a chemokine (C-C motif) ligand 2-dependent manner in pathogenesis of oral submucous fibrosis.
Sarode G; Sarode SC; Deshmukh R; Raktade P; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):443-447. PubMed ID: 28029690
[TBL] [Abstract][Full Text] [Related]
70. Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma.
Chaudhary AK; Pandya S; Mehrotra R; Bharti AC; Singh M; Singh M
Virol J; 2010 Sep; 7():253. PubMed ID: 20863370
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of Salivary Opiorphin, pH and Flow Rate in Oral Submucous Fibrosis - A Case - Control Observational Study.
Varsha KS; Lakshmi KC; Ganesan A; Kannan A; Aniyan KY
J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 1):S656-S660. PubMed ID: 37654371
[TBL] [Abstract][Full Text] [Related]
72. Estimation of serum sialic acid in oral submucous fibrosis and oral squamous cell carcinoma.
Chittemsetti S; Manchikatla PK; Guttikonda V
J Oral Maxillofac Pathol; 2019; 23(1):156. PubMed ID: 31110436
[TBL] [Abstract][Full Text] [Related]
73. Caspase-3 expression in normal oral epithelium, oral submucous fibrosis and oral squamous cell carcinoma.
Veeravarmal V; Austin RD; Siddavaram N; Thiruneelakandan S; Nassar MH
J Oral Maxillofac Pathol; 2016; 20(3):445-452. PubMed ID: 27721610
[TBL] [Abstract][Full Text] [Related]
74. Expression of p63 and Proliferating Cell Nuclear Antigen in Oral Submucous Fibrosis.
Suwasini S; Shrikaar M; Kumari N; Singh A; Kumari K; Kumar M
J Int Soc Prev Community Dent; 2021; 11(4):448-456. PubMed ID: 34430507
[TBL] [Abstract][Full Text] [Related]
75. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study.
Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS
J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271
[TBL] [Abstract][Full Text] [Related]
76. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of Hematological profile in Oral Submucous Fibrosis: A Cross-sectional Study.
Patil DJ; Joshi M
J Oral Maxillofac Pathol; 2020; 24(3):575. PubMed ID: 33967501
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of plasma fibrinogen degradation products and total serum protein concentration in oral submucous fibrosis.
Kadani M; B N V S S; B M; K M P; Hugar D; Allad U; Prabhu PS
J Clin Diagn Res; 2014 May; 8(5):ZC54-7. PubMed ID: 24995245
[TBL] [Abstract][Full Text] [Related]
79. HIF - 1α as a marker of risk assessment for malignant transformation in oral submucous fibrosis: An immunohistochemical study.
Sharma K; Shetty DC; Rathore AS; Juneja SA; Katyal S; Krishnatre A
Indian J Pathol Microbiol; 2022; 65(4):761-765. PubMed ID: 36308177
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of salivary endothelin-1 as a biomarker for oral cancer and precancer.
Irfan S; Zaidi N; Tiwari K; Lal N; Srivastava AN; Singh S
J Cancer Res Ther; 2023 Dec; ():. PubMed ID: 38102911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
